Summary
Pharmaceuticals in India industry profile provides top-line qualitative and quantitative summary information including: market size (value 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Indian pharmaceuticals market had total revenues of $38.2m in 2018, representing a compound annual growth rate (CAGR) of 15.4% between 2014 and 2018.
- The performance of the market is forecast to decelerate, with an anticipated CAGR of 13.7% for the five-year period 2018-2023, which is expected to drive the market to a value of $72.7m by the end of 2023.
- Investment and regulatory change within the industry are set to drive India’s pharmaceutical companies towards higher value drugs such as biosimilars and incentivise domestic innovation.
Scope
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in India
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in India
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the India pharmaceuticals market with five year forecasts
Reasons to buy
- What was the size of the India pharmaceuticals market by value in 2018?
- What will be the size of the India pharmaceuticals market in 2023?
- What factors are affecting the strength of competition in the India pharmaceuticals market?
- How has the market performed over the last five years?
- How large is India’s pharmaceuticals market in relation to its regional counterparts?
'
Table of Contents
Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Aurobindo Pharma Limited
Dr. Reddy's Laboratories Limited
Lupin Ltd
Sun Pharmaceutical Industries Ltd
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine
List of Tables
Table 1: India pharmaceuticals market value: $ billion, 2014-18
Table 2: India pharmaceuticals market geography segmentation: $ billion, 2018
Table 3: India pharmaceuticals market share: % share, by value, 2018
Table 4: India pharmaceuticals market value forecast: $ billion, 2018-23
Table 5: Aurobindo Pharma Limited: key facts
Table 6: Aurobindo Pharma Limited: key financials ($)
Table 7: Aurobindo Pharma Limited: key financials (Rs.)
Table 8: Aurobindo Pharma Limited: key financial ratios
Table 9: Dr. Reddy's Laboratories Limited: key facts
Table 10: Dr. Reddy's Laboratories Limited: key financials ($)
Table 11: Dr. Reddy's Laboratories Limited: key financials (Rs.)
Table 12: Dr. Reddy's Laboratories Limited: key financial ratios
Table 13: Lupin Ltd: key facts
Table 14: Lupin Ltd: key financials ($)
Table 15: Lupin Ltd: key financials (Rs.)
Table 16: Lupin Ltd: key financial ratios
Table 17: Sun Pharmaceutical Industries Ltd: key facts
Table 18: Sun Pharmaceutical Industries Ltd: key financials ($)
Table 19: Sun Pharmaceutical Industries Ltd: key financials (Rs.)
Table 20: Sun Pharmaceutical Industries Ltd: key financial ratios
Table 21: India size of population (million), 2014-18
Table 22: India gdp (constant 2005 prices, $ billion), 2014-18
Table 23: India gdp (current prices, $ billion), 2014-18
Table 24: India inflation, 2014-18
Table 25: India consumer price index (absolute), 2014-18
Table 26: India exchange rate, 2014-18
List of Figures
Figure 1: India pharmaceuticals market value: $ billion, 2014-18
Figure 2: India pharmaceuticals market geography segmentation: % share, by value, 2018
Figure 3: India pharmaceuticals market share: % share, by value, 2018
Figure 4: India pharmaceuticals market value forecast: $ billion, 2018-23
Figure 5: Forces driving competition in the pharmaceuticals market in India, 2018
Figure 6: Drivers of buyer power in the pharmaceuticals market in India, 2018
Figure 7: Drivers of supplier power in the pharmaceuticals market in India, 2018
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in India, 2018
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in India, 2018
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in India, 2018
Figure 11: Aurobindo Pharma Limited: revenues & profitability
Figure 12: Aurobindo Pharma Limited: assets & liabilities
Figure 13: Dr. Reddy's Laboratories Limited: revenues & profitability
Figure 14: Dr. Reddy's Laboratories Limited: assets & liabilities
Figure 15: Lupin Ltd: revenues & profitability
Figure 16: Lupin Ltd: assets & liabilities
Figure 17: Sun Pharmaceutical Industries Ltd: revenues & profitability
Figure 18: Sun Pharmaceutical Industries Ltd: assets & liabilities
